Keep Us Strong WikiLeaks logo

Currently released so far... 97115 / 251,287

Articles

Browse latest releases

Browse by creation date

Browse by origin

A B C D F G H I J K L M N O P Q R S T U V W Y Z

Browse by tag

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
ETRD EAGR ETTC EAID ECON EFIN ECIN EINV ELAB EAIR ENRG EPET EWWT ECPS EIND EMIN ELTN EC ETMIN EUC EZ ET ELECTIONS ENVR EU EUN EG EINT ER ECONOMICS ES EMS ENIV EEB EN ECE ECOSOC EK ENVIRONMENT EFIS EI EWT ENGRD ECPSN EXIM EIAD ERIN ECPC EDEV ENGY ECTRD EPA ESTH ECCT EINVECON ENGR ERTD EUR EAP EWWC ELTD EL EXIMOPIC EXTERNAL ETRDEC ESCAP ECO EGAD ELNT ECONOMIC ENV ETRN EIAR EUMEM ENRGPARMOTRASENVKGHGPGOVECONTSPLEAID EREL ECOM ECONETRDEAGRJA ETCC ETRG ECONOMY EMED ETR ENERG EITC EFINOECD EURM EENG ERA EXPORT ENRD ECONEINVETRDEFINELABETRDKTDBPGOVOPIC EGEN EBRD EVIN ETRAD ECOWAS EFTA ECONETRDBESPAR EGOVSY EPIN EID ECONENRG EDRC ESENV ETT EB ENER ELTNSNAR ECHEVARRIA ETRC EPIT EDUC ESA EFI ENRGY ESCI EE EAIDXMXAXBXFFR EETC ECIP EIAID EIVN EBEXP ESTN EING EGOV ETRA EPETEIND ELAN ETRDGK EAIDRW ETRDEINVECINPGOVCS EPEC ENVI ELN EAG EPCS EPRT EPTED ETRB EUM EAIDS EFIC EFINECONEAIDUNGAGM EAIDAR ESF EIDN ELAM EDU EV EAIDAF ECN EDA EXBS EINTECPS ENRGTRGYETRDBEXPBTIOSZ EPREL EAC EINVEFIN ETA EAGER EINDIR ECA ECLAC ELAP EITI EUCOM ECONEFINETRDPGOVEAGRPTERKTFNKCRMEAID EARG ELDIN EINVKSCA ENNP EFINECONCS EFINTS ECCP ETC EAIRASECCASCID EINN ETRP EAIDNI EFQ ECOQKPKO EGPHUM EBUD ECONEINVEFINPGOVIZ ENERGY ELB EINDETRD EMI ECONEFIN EIB EURN ETRDEINVTINTCS EIN EFIM ETIO ELAINE EMN EATO EWTR EIPR EINVETC ETTD ETDR EIQ ECONCS EPPD ENRGIZ EISL ESPINOSA ELEC EAIG ESLCO EUREM ENTG ERD EINVECONSENVCSJA EEPET EUNCH ECINECONCS ETRO ETRDECONWTOCS ECUN EFND EPECO EAIRECONRP ERGR ETRDPGOV ECPN ENRGMO EPWR EET EAIS EAGRE EDUARDO EAGRRP EAIDPHUMPRELUG EICN ECONQH EVN EGHG ELBR EINF EAIDHO EENV ETEX ERNG ED
KMDR KPAO KPKO KJUS KCRM KGHG KFRD KWMN KDEM KTFN KHIV KGIC KIDE KSCA KNNP KHUM KIPR KSUM KISL KIRF KCOR KRCM KPAL KWBG KN KS KOMC KSEP KFLU KPWR KTIA KSEO KMPI KHLS KICC KSTH KMCA KVPR KPRM KE KU KZ KFLO KSAF KTIP KTEX KBCT KOCI KOLY KOR KAWC KACT KUNR KTDB KSTC KLIG KSKN KNN KCFE KCIP KGHA KHDP KPOW KUNC KDRL KV KPREL KCRS KPOL KRVC KRIM KGIT KWIR KT KIRC KOMO KRFD KUWAIT KG KFIN KSCI KTFIN KFTN KGOV KPRV KSAC KGIV KCRIM KPIR KSOC KBIO KW KGLB KMWN KPO KFSC KSEAO KSTCPL KSI KPRP KREC KFPC KUNH KCSA KMRS KNDP KR KICCPUR KPPAO KCSY KTBT KCIS KNEP KFRDCVISCMGTCASCKOCIASECPHUMSMIGEG KNNB KGCC KINR KPOP KMFO KENV KNAR KVIR KDRG KDMR KFCE KNAO KDEN KGCN KICA KIMMITT KMCC KLFU KMSG KSEC KUM KCUL KMNP KSMT KCOM KOMCSG KSPR KPMI KRAD KIND KCRP KAUST KWAWC KTER KCHG KRDP KPAS KITA KTSC KPAOPREL KWGB KIRP KJUST KMIG KLAB KTFR KSEI KSTT KAPO KSTS KLSO KWNN KPOA KHSA KNPP KPAONZ KBTS KWWW KY KJRE KPAOKMDRKE KCRCM KSCS KWMNCI KESO KWUN KPLS KIIP KEDEM KPAOY KRIF KGICKS KREF KTRD KFRDSOCIRO KTAO KJU KWMNPHUMPRELKPAOZW KEN KO KNEI KEMR KKIV KEAI KWAC KRCIM KWCI KFIU KWIC KCORR KOMS KNNO KPAI KBWG KTTB KTBD KTIALG KILS KFEM KTDM KESS KNUC KPA KOMCCO KCEM KRCS KWBGSY KNPPIS KNNPMNUC KWN KERG KLTN KALM KCCP KSUMPHUM KREL KGH KLIP KTLA KAWK KWMM KVRP KVRC KAID KSLG KDEMK KX KIF KNPR KCFC KFTFN KTFM KPDD KCERS KMOC KDEMAF KMEPI KEMS KDRM KEPREL KBTR KEDU KNP KIRL KNNR KMPT KISLPINR KTPN KA KJUSTH KPIN KDEV KTDD KAKA KFRP KWNM KTSD KINL KJUSKUNR KWWMN KECF KWBC KPRO KVBL KOM KFRDKIRFCVISCMGTKOCIASECPHUMSMIGEG KEDM KFLD KLPM KRGY KNNF KICR KIFR KM KWMNCS KAWS KLAP KPAK KDDG KCGC KID KNSD KMPF KPFO KDP KCMR KRMS KNPT KNNNP KTIAPARM KDTB KNUP KPGOV KNAP KNNC KUK KSRE KREISLER KIVP KQ KTIAEUN KPALAOIS KRM KISLAO KWM KFLOA
PHUM PINR PTER PGOV PREL PREF PL PM PHSA PE PARM PINS PK PUNE PO PALESTINIAN PU PBTS PROP PTBS POL POLI PA PGOVZI POLMIL POLITICAL PARTIES POLM PD POLITICS POLICY PAS PMIL PINT PNAT PV PKO PPOL PERSONS PING PBIO PH PETR PARMS PRES PCON PETERS PRELBR PT PLAB PP PAK PDEM PKPA PSOCI PF PLO PTERM PJUS PSOE PELOSI PROPERTY PGOVPREL PARP PRL PNIR PHUMKPAL PG PREZ PGIC PBOV PAO PKK PROV PHSAK PHUMPREL PROTECTION PGOVBL PSI PRELPK PGOVENRG PUM PRELKPKO PATTY PSOC PRIVATIZATION PRELSP PGOVEAIDUKNOSWGMHUCANLLHFRSPITNZ PMIG PREC PAIGH PROG PSHA PARK PETER POG PHUS PPREL PS PTERPREL PRELPGOV POV PKPO PGOVECON POUS PGOVPRELPHUMPREFSMIGELABEAIDKCRMKWMN PWBG PMAR PREM PAR PNR PRELPGOVEAIDECONEINVBEXPSCULOIIPBTIO PARMIR PGOVGM PHUH PARTM PN PRE PTE PY POLUN PPEL PDOV PGOVSOCI PIRF PGOVPM PBST PRELEVU PGOR PBTSRU PRM PRELKPAOIZ PGVO PERL PGOC PAGR PMIN PHUMR PVIP PPD PGV PRAM PINL PKPAL PTERE PGOF PINO PHAS PODC PRHUM PHUMA PREO PPA PEPFAR PGO PRGOV PAC PRESL PORG PKFK PEPR PRELP PREFA PNG PGOVPHUMKPAO PRELECON PINOCHET PFOR PGOVLO PHUMBA PRELC PREK PHUME PHJM POLINT PGOVPZ PGOVKCRM PGOVE PHALANAGE PARTY PECON PEACE PROCESS PLN PRELSW PAHO PEDRO PRELA PASS PPAO PGPV PNUM PCUL PGGV PSA PGOVSMIGKCRMKWMNPHUMCVISKFRDCA PGIV PRFE POGOV PEL PBT PAMQ PINF PSEPC POSTS PHUMPGOV PVOV PHSAPREL PROLIFERATION PENA PRELTBIOBA PIN PRELL PGOVPTER PHAM PHYTRP PTEL PTERPGOV PHARM PROTESTS PRELAF PKBL PRELKPAO PKNP PARMP PHUML PFOV PERM PUOS PRELGOV PHUMPTER PARAGRAPH PERURENA PBTSEWWT PCI PETROL PINSO PINSCE PQL PEREZ PBS

Browse by classification

Community resources

courage is contagious

Viewing cable 06WELLINGTON481, NEW ZEALAND REVIEWING MEDICINES POLICY

If you are new to these pages, please read an introduction on the structure of a cable as well as how to discuss them with others. See also the FAQs

Understanding cables
Every cable message consists of three parts:
  • The top box shows each cables unique reference number, when and by whom it originally was sent, and what its initial classification was.
  • The middle box contains the header information that is associated with the cable. It includes information about the receiver(s) as well as a general subject.
  • The bottom box presents the body of the cable. The opening can contain a more specific subject, references to other cables (browse by origin to find them) or additional comment. This is followed by the main contents of the cable: a summary, a collection of specific topics and a comment section.
To understand the justification used for the classification of each cable, please use this WikiSource article as reference.

Discussing cables
If you find meaningful or important information in a cable, please link directly to its unique reference number. Linking to a specific paragraph in the body of a cable is also possible by copying the appropriate link (to be found at theparagraph symbol). Please mark messages for social networking services like Twitter with the hash tags #cablegate and a hash containing the reference ID e.g. #06WELLINGTON481.
Reference ID Created Released Classification Origin
06WELLINGTON481 2006-06-22 23:45 2011-04-28 00:00 UNCLASSIFIED//FOR OFFICIAL USE ONLY Embassy Wellington
VZCZCXRO8032
RR RUEHNZ
DE RUEHWL #0481/01 1732345
ZNR UUUUU ZZH
R 222345Z JUN 06
FM AMEMBASSY WELLINGTON
TO RUEHC/SECSTATE WASHDC 2939
INFO RUCPDOC/USDOC WASHDC 0064
RUEHNZ/AMCONSUL AUCKLAND 0807
RUEHBY/AMEMBASSY CANBERRA 4461
RUEHDN/AMCONSUL SYDNEY 0450
UNCLAS SECTION 01 OF 02 WELLINGTON 000481 
 
SIPDIS 
 
SENSITIVE 
SIPDIS 
 
STATE PASS USTR-JJENSEN 
STATE FOR EAP/ANP-DRICCI AND EB/TPP/BTA/ANA-MBGOODMAN 
COMMERCE FOR ABENAISSA/4530/ITA/MAC/AP/OSAO 
SYDNEY FOR CS 
 
E.O. 12958: N/A 
TAGS: ETRD ECON NZ
SUBJECT: NEW ZEALAND REVIEWING MEDICINES POLICY 
 
REF: WELLINGTON 40 
 
1.  (SBU) Summary:  The New Zealand government has launched a review 
of its long-term medicines strategy, aiming to identify ways to 
improve the drug-purchasing system that controls the range and price 
of most prescription medicines in the country.  The review follows 
more than a year of escalating public complaints over the 
government's failure to fund a number of high-priced medicines for a 
range of illnesses.  Both the pharmaceutical industry and the 
government's drug-buying agency have welcomed the review.  End 
summary. 
 
2. (U) Associate Health Minister Peter Dunne formally announced the 
review on April 13.  The ruling Labour Party had committed to such a 
review as part of its agreement with Dunne's United Future party to 
form a government after the September 17 elections.  The opposition 
National Party -- which created the drug-purchasing entity, the 
Pharmaceutical Management Agency (PHARMAC), while in government in 
1993 -- also supports the review. 
 
3. (U) The review will focus on three areas:  access to medicines, 
particularly to new and high-cost medicines, which would include 
looking at PHARMAC's role in assessing which medicines should be 
publicly funded; the quality of medicines available in New Zealand; 
and, the rational use of medicines, or ensuring that medicines are 
not used to unnecessarily prolong or even cause ill health.  The 
review also will assess how the pharmaceutical budget is set, 
whether it is adequate and whether it should continue to be part of 
District Health Board spending plans.  There are 21 such boards in 
New Zealand, responsible for providing government-funded health care 
services for the population in a designated geographical area. 
 
4. (U) For the review, the Ministry of Health is consulting a 
variety of groups, including the industry, government departments, 
health practitioners and patients' and consumer groups.  The 
Ministry also is studying systems in such countries as Australia, 
Canada, Ireland and the United Kingdom.  The Ministry will draft a 
report to be submitted to Cabinet for approval by November and then 
released for public comments by year's end.  In early 2007, 
government ministers are expected to receive the Ministry's 
recommendations on next steps and then decide whether and how to 
implement them. 
 
5. (SBU) The review is one reason why the pharmaceutical industry is 
cautiously optimistic about the prospect of changes to the 
drug-purchasing system, which has crimped the industry for the past 
13 years (reftel).  An industry representative noted that Minister 
Dunne has instructed the Ministry to ensure the report reflects the 
opinions of those affected by the medicines policy.  So far, the 
representative said, the consultations have been inclusive and 
collaborative.  The industry hopes the review will achieve -- at a 
minimum -- "more realistic funding" for pharmaceuticals and greater 
transparency in PHARMAC's decision-making. 
 
6. (SBU) Meanwhile, PHARMAC hopes the review will result in an 
increase in its budget for drug purchases.  The agency has found it 
increasingly difficult to choose between funding expensive drugs for 
less common diseases and funding cheaper medicines that help larger 
numbers of patients.  Its decisions in the past year have focused 
greater public attention to the plight of patients with 
life-threatening diseases who were unable to afford unsubsidized 
medicines.  PHARMAC has been reviewing its decision-making process 
for high-cost drugs, which may serve as input for the medicines 
strategy review. 
 
7. (SBU) Dunne has criticized PHARMAC for emphasizing cost 
containment when deciding which medicines to subsidize.  A Ministry 
of Health official, however, warned against expecting a huge 
increase in the pharmaceutical budget. 
 
8. (SBU) The official also cautioned against turning the 
consultations into an attack on PHARMAC.  For example, pointing out 
that Australia subsidizes a larger number of medicines than New 
Zealand would be a "fruitless exercise," the official said. 
Instead, an appropriate question might be how Australia decides its 
funding priorities. 
 
9. (SBU) Comment: Post understands that the medicines strategy 
review will be discussed at the U.S.-New Zealand Trade and 
Investment Framework Agreement talks set for June 27. 
Pharmaceutical industry representatives say they hope the U.S. side 
will acknowledge the review in a positive way, without any measure 
of pressure.  The industry is pleased that the government has 
undertaken the review, wants to be seen as a constructive partner 
 
WELLINGTON 00000481  002 OF 002 
 
 
and hopes to preserve the cooperative spirit that so far has marked 
the consultations. 
 
MCCORMICK